BioCentury
ARTICLE | Politics, Policy & Law

Grassley-Wyden drug price bill attacks rebates, includes inflation caps

March 16, 2020 10:33 PM UTC

A revised version of bipartisan Senate drug pricing legislation would pass Medicare Part D rebates to beneficiaries, rather than drug plans.

The Congressional Budget Office estimates the Prescription Drug Pricing Reduction Act, co-sponsored by Sens. Chuck Grassley (R-Iowa) and Ron Wyden (D-Ore.), would save the federal government $95 billion and reduce Medicare beneficiaries’ out-of-pocket costs $72 billion over 10 years...